Thiazolidinediones and rexinoids induce peroxisome proliferator-activated receptor-coactivator (PGC)-1α gene transcription : An autoregulatory loop controls PGC-1α expression in adipocytes via peroxisome proliferator-activated receptor-γ coactivationHONDARES, Elayne; MORA, Ofelia; YUBERO, Pilar et al.Endocrinology (Philadelphia). 2006, Vol 147, Num 6, pp 2829-2838, issn 0013-7227, 10 p.Article

Anti-inflammatory actions of perfluorooctanoic acid and peroxisome proliferator-activated receptors (PPAR) α and γ in experimental acute pancreatitis : Comeback for kininsGRIESBACHER, Thomas; POMMER, Veronika; SCHULIGOI, Rufina et al.International immunopharmacology. 2008, Vol 8, Num 2, pp 325-329, issn 1567-5769, 5 p.Conference Paper

Rational Targeting of Peroxisome Proliferating Activated Receptor SubtypesNEVIN, D. K; LLOYD, D. G; FAYNE, D et al.Current medicinal chemistry. 2011, Vol 18, Num 36, pp 5598-5623, issn 0929-8673, 26 p.Article

PPAR control: it's SIRTainly as easy as PGCSUGDEN, Mary C; CATON, Paul W; HOLNESS, Mark et al.Journal of endocrinology. 2010, Vol 204, Num 2, pp 93-104, issn 0022-0795, 12 p.Article

Peroxisome proliferator-activated receptor-alpha agonists repress expression of thrombin-activatable fibrinolysis inhibitor by decreasing transcript stabilityMASUDA, Yutaka; SAOTOME, Dan; TAKADA, Kimihiko et al.Thrombosis and haemostasis. 2012, Vol 108, Num 1, pp 74-85, issn 0340-6245, 12 p.Article

Antidiabetic and hypolipidemic potential of DRF 2519: a dual activator of PPAR-α and PPAR-γCHAKRABARTI, Ranjan; MISRA, Parimal; VIKRAMADITHYAN, Reeba K et al.European journal of pharmacology. 2004, Vol 491, Num 2-3, pp 195-206, issn 0014-2999, 12 p.Article

Dual Acting and Pan-PPAR Activators as Potential Anti-diabetic TherapiesHEALD, Monique; CAWTHORNE, Michael A.Handbook of experimental pharmacology. 2011, Vol 203, pp 35-51, issn 0171-2004, 17 p.Article

Transcriptional regulation of the GLUT4 gene : from PPAR-γ and FOXO1 to FFA and inflammationARMONI, Michal; HAREL, Chava; KARNIELI, Eddy et al.Trends in endocrinology and metabolism. 2007, Vol 18, Num 3, pp 100-107, issn 1043-2760, 8 p.Article

Peroxisome proliferator-activated receptor translational research and clinical experienceWENDELL CHEATHAM, Wayman.The American journal of clinical nutrition. 2010, Vol 91, Num 1, issn 0002-9165, 262S-266SConference Paper

Bidirectional fluorescence properties of pyrene-based peroxisome proliferator-activated receptor (PPAR) α/δ dual agonistBAN, Shintaro; OYAMA, Takuji; KASUGA, Jun-Ichi et al.Bioorganic & medicinal chemistry. 2012, Vol 20, Num 11, pp 3460-3464, issn 0968-0896, 5 p.Article

Expression of peroxisome proliferator-activated receptors in human testicular cancer and growth inhibition by its agonistsHASE, Taro; YOSHIMURA, Rikio; MITSUHASHI, Makoto et al.Urology (Ridgewood, NJ). 2002, Vol 60, Num 3, pp 542-547, issn 0090-4295Article

Design, synthesis and evaluation of novel zwitterionic compounds as PPARα/γ dual agonists (1)SHIBATA, Yoshihiro; KAGECHIKA, Katsuji; YAMAGUCHI, Mitsuhiro et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 23, pp 7075-7079, issn 0960-894X, 5 p.Article

Effect of topical PPARβ/δ and PPARy agonists on plaque psoriasis: A pilot studyKUENZLI, Stéphane; SAURAT, Jean-Hilaire.Dermatology (Basel). 2003, Vol 206, Num 3, pp 252-256, issn 1018-8665, 5 p.Article

The Cardiovascular Effects of Peroxisome Proliferator-activated Receptor AgonistsFRIEDLAND, Sayuri N; LEONG, Aaron; FILION, Kristian B et al.The American journal of medicine. 2012, Vol 125, Num 2, pp 126-133, issn 0002-9343, 8 p.Article

PPARs at the crossroads of lipid signaling and inflammationWAHLI, Walter; MICHALIK, Liliane.Trends in endocrinology and metabolism. 2012, Vol 23, Num 7, pp 351-363, issn 1043-2760, 13 p.Article

Minireview : The paired box-8/peroxisome proliferator-activated receptor-y oncogene in thyroid tumorigenesisREDDI, Honey V; MCIVER, Bryan; GREBE, Stefan K. G et al.Endocrinology (Philadelphia). 2007, Vol 148, Num 3, pp 932-935, issn 0013-7227, 4 p.Article

Alterations in skin and stratified epithelia by constitutively activated PPARα. CommentaryDUBRAC, Sandrine; SCHMUTH, Matthias; QIAN YANG et al.Journal of investigative dermatology. 2006, Vol 126, Num 2, issn 0022-202X, 241-242,374-385 [14 p.]Article

A novel peroxisome proliferator-activated receptor α/γ dual agonist demonstrates favorable effects on lipid homeostasisGUO, Qiu; SAHOO, Soumya P; SHARMA, Neelam et al.Endocrinology (Philadelphia). 2004, Vol 145, Num 4, pp 1640-1648, issn 0013-7227, 9 p.Article

Peroxisome proliferator-activated receptor γ-dependent activation of p21 in Panc-28 pancreatic cancer cells involves sp1 and Sp4 proteinsJUN HONG; SAMUDIO, Ismael; SHENGXI LIU et al.Endocrinology (Philadelphia). 2004, Vol 145, Num 12, pp 5774-5785, issn 0013-7227, 12 p.Article

Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α): Transcriptional coactivator and metabolic regulatorPUIGSERVER, Pere; SPIEGELMAN, Bruce M.Endocrine reviews. 2003, Vol 24, Num 1, pp 78-90, issn 0163-769X, 13 p.Article

Peroxisome Proliferator-Activated Receptor-γ-Mediated Effects in the VasculatureSHENG ZHONG DUAN; USHER, Michael G; MORTENSEN, Richard M et al.Circulation research. 2008, Vol 102, Num 3, pp 283-294, issn 0009-7330, 12 p.Article

Tumor angiogenesis suppression by α-eleostearic acid, a linolenic acid isomer with a conjugated triene system, via peroxisome proliferator-activated receptor γTSUZUKI, Tsuyoshi; KAWAKAMI, Yuki.Carcinogenesis (New York. Print). 2008, Vol 29, Num 4, pp 797-806, issn 0143-3334, 10 p.Article

Activation of PPARδ inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblastsTEUNISSEN, Birgit E. J; SMEETS, Pascal J. H; WILLEMSEN, Peter H. M et al.Cardiovascular research. 2007, Vol 75, Num 3, pp 519-529, issn 0008-6363, 11 p.Article

Suppression of PPAR-γ attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytesWEI LIAO; NGUYEN, M. T. Audrey; YOSHIZAKI, Takeshi et al.American journal of physiology. Endocrinology and metabolism. 2007, Vol 56, Num 1, issn 0193-1849, E219-E227Article

Muraglitazar, a novel dual (α/γ) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves β-cell function in db/db miceHARRITY, Thomas; FARRELLY, Dennis; WEI WANG et al.Diabetes (New York, NY). 2006, Vol 55, Num 1, pp 240-248, issn 0012-1797, 9 p.Article